Better heart attack prediction from new cholesterol tests?

Published: June, 2006

Two simple tests could someday elbow aside, or at least complement, today's standard cholesterol tests.

A multibillion-dollar industry rests on the squishy, fat-filled particle known as low-density lipoprotein (LDL), the so-called bad cholesterol. LDL is the foundation on which the current cholesterol guidelines were built. It is the focus of millions of yearly blood tests. And it is the main target of cholesterol-lowering statins, for which Americans shelled out nearly $20 billion in 2005.

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »